Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ibrutinib | Icosapent may increase the antiplatelet activities of Ibrutinib. |
| Amlodipine | Icosapent may decrease the antihypertensive activities of Amlodipine. |
| Phentermine | The risk or severity of hypertension can be increased when Icosapent is combined with Phentermine. |
| Midodrine | The risk or severity of hypertension can be increased when Icosapent is combined with Midodrine. |
| Eletriptan | The risk or severity of hypertension can be increased when Icosapent is combined with Eletriptan. |
| Isoetharine | The risk or severity of hypertension can be increased when Icosapent is combined with Isoetharine. |
| Ziprasidone | The risk or severity of hypertension can be increased when Icosapent is combined with Ziprasidone. |
| Methysergide | The risk or severity of hypertension can be increased when Icosapent is combined with Methysergide. |
| Cabergoline | The risk or severity of hypertension can be increased when Icosapent is combined with Cabergoline. |
| Zolmitriptan | The risk or severity of hypertension can be increased when Icosapent is combined with Zolmitriptan. |
| Dihydroergotamine | The risk or severity of hypertension can be increased when Icosapent is combined with Dihydroergotamine. |
| Methylergometrine | The risk or severity of hypertension can be increased when Icosapent is combined with Methylergometrine. |
| Norepinephrine | The risk or severity of hypertension can be increased when Icosapent is combined with Norepinephrine. |
| Mirtazapine | The risk or severity of hypertension can be increased when Icosapent is combined with Mirtazapine. |
| Phenylephrine | The risk or severity of hypertension can be increased when Icosapent is combined with Phenylephrine. |
| Phenylpropanolamine | The risk or severity of hypertension can be increased when Icosapent is combined with Phenylpropanolamine. |
| Promazine | The risk or severity of hypertension can be increased when Icosapent is combined with Promazine. |
| Droperidol | The risk or severity of hypertension can be increased when Icosapent is combined with Droperidol. |
| Doxapram | The risk or severity of hypertension can be increased when Icosapent is combined with Doxapram. |
| Atropine | The risk or severity of hypertension can be increased when Icosapent is combined with Atropine. |
| Lisuride | The risk or severity of hypertension can be increased when Icosapent is combined with Lisuride. |
| Linezolid | The risk or severity of hypertension can be increased when Icosapent is combined with Linezolid. |
| Metaraminol | The risk or severity of hypertension can be increased when Icosapent is combined with Metaraminol. |
| Furazolidone | The risk or severity of hypertension can be increased when Icosapent is combined with Furazolidone. |
| Epinephrine | The risk or severity of hypertension can be increased when Icosapent is combined with Epinephrine. |
| Thioridazine | The risk or severity of hypertension can be increased when Icosapent is combined with Thioridazine. |
| Ergotamine | The risk or severity of hypertension can be increased when Icosapent is combined with Ergotamine. |
| Nicergoline | The risk or severity of hypertension can be increased when Icosapent is combined with Nicergoline. |
| Sufentanil | The risk or severity of hypertension can be increased when Icosapent is combined with Sufentanil. |
| Methoxamine | The risk or severity of hypertension can be increased when Icosapent is combined with Methoxamine. |
| Risperidone | The risk or severity of hypertension can be increased when Icosapent is combined with Risperidone. |
| Tranylcypromine | The risk or severity of hypertension can be increased when Icosapent is combined with Tranylcypromine. |
| Isoflurane | The risk or severity of hypertension can be increased when Icosapent is combined with Isoflurane. |
| Propiomazine | The risk or severity of hypertension can be increased when Icosapent is combined with Propiomazine. |
| Alfentanil | The risk or severity of hypertension can be increased when Icosapent is combined with Alfentanil. |
| Minaprine | The risk or severity of hypertension can be increased when Icosapent is combined with Minaprine. |
| Orciprenaline | The risk or severity of hypertension can be increased when Icosapent is combined with Orciprenaline. |
| Propofol | The risk or severity of hypertension can be increased when Icosapent is combined with Propofol. |
| Phenmetrazine | The risk or severity of hypertension can be increased when Icosapent is combined with Phenmetrazine. |
| Trifluoperazine | The risk or severity of hypertension can be increased when Icosapent is combined with Trifluoperazine. |
| Pseudoephedrine | The risk or severity of hypertension can be increased when Icosapent is combined with Pseudoephedrine. |
| Benzphetamine | The risk or severity of hypertension can be increased when Icosapent is combined with Benzphetamine. |
| Ritodrine | The risk or severity of hypertension can be increased when Icosapent is combined with Ritodrine. |
| Flupentixol | The risk or severity of hypertension can be increased when Icosapent is combined with Flupentixol. |
| Remifentanil | The risk or severity of hypertension can be increased when Icosapent is combined with Remifentanil. |
| Bitolterol | The risk or severity of hypertension can be increased when Icosapent is combined with Bitolterol. |
| Oxymetazoline | The risk or severity of hypertension can be increased when Icosapent is combined with Oxymetazoline. |
| Diethylpropion | The risk or severity of hypertension can be increased when Icosapent is combined with Diethylpropion. |
| Salmeterol | The risk or severity of hypertension can be increased when Icosapent is combined with Salmeterol. |
| Naratriptan | The risk or severity of hypertension can be increased when Icosapent is combined with Naratriptan. |
| Formoterol | The risk or severity of hypertension can be increased when Icosapent is combined with Formoterol. |
| Frovatriptan | The risk or severity of hypertension can be increased when Icosapent is combined with Frovatriptan. |
| Methoxyflurane | The risk or severity of hypertension can be increased when Icosapent is combined with Methoxyflurane. |
| Selegiline | The risk or severity of hypertension can be increased when Icosapent is combined with Selegiline. |
| Ergoloid mesylate | The risk or severity of hypertension can be increased when Icosapent is combined with Ergoloid mesylate. |
| Isoprenaline | The risk or severity of hypertension can be increased when Icosapent is combined with Isoprenaline. |
| Arbutamine | The risk or severity of hypertension can be increased when Icosapent is combined with Arbutamine. |
| Dutasteride | The risk or severity of hypertension can be increased when Icosapent is combined with Dutasteride. |
| Halothane | The risk or severity of hypertension can be increased when Icosapent is combined with Halothane. |
| Moclobemide | The risk or severity of hypertension can be increased when Icosapent is combined with Moclobemide. |
| Pergolide | The risk or severity of hypertension can be increased when Icosapent is combined with Pergolide. |
| Desflurane | The risk or severity of hypertension can be increased when Icosapent is combined with Desflurane. |
| Bromocriptine | The risk or severity of hypertension can be increased when Icosapent is combined with Bromocriptine. |
| Finasteride | The risk or severity of hypertension can be increased when Icosapent is combined with Finasteride. |
| Aripiprazole | The risk or severity of hypertension can be increased when Icosapent is combined with Aripiprazole. |
| Isocarboxazid | The risk or severity of hypertension can be increased when Icosapent is combined with Isocarboxazid. |
| Ergometrine | The risk or severity of hypertension can be increased when Icosapent is combined with Ergometrine. |
| Lisdexamfetamine | The risk or severity of hypertension can be increased when Icosapent is combined with Lisdexamfetamine. |
| Fenoterol | The risk or severity of hypertension can be increased when Icosapent is combined with Fenoterol. |
| Pirbuterol | The risk or severity of hypertension can be increased when Icosapent is combined with Pirbuterol. |
| Ephedra sinica root | The risk or severity of hypertension can be increased when Icosapent is combined with Ephedra sinica root. |
| Ephedrine | The risk or severity of hypertension can be increased when Icosapent is combined with Ephedrine. |
| Mephentermine | The risk or severity of hypertension can be increased when Icosapent is combined with Mephentermine. |
| Procaterol | The risk or severity of hypertension can be increased when Icosapent is combined with Procaterol. |
| Yohimbine | The risk or severity of hypertension can be increased when Icosapent is combined with Yohimbine. |
| Methotrimeprazine | The risk or severity of hypertension can be increased when Icosapent is combined with Methotrimeprazine. |
| Clenbuterol | The risk or severity of hypertension can be increased when Icosapent is combined with Clenbuterol. |
| Bambuterol | The risk or severity of hypertension can be increased when Icosapent is combined with Bambuterol. |
| MMDA | The risk or severity of hypertension can be increased when Icosapent is combined with MMDA. |
| Midomafetamine | The risk or severity of hypertension can be increased when Icosapent is combined with Midomafetamine. |
| 2,5-Dimethoxy-4-ethylamphetamine | The risk or severity of hypertension can be increased when Icosapent is combined with 2,5-Dimethoxy-4-ethylamphetamine. |
| 4-Methoxyamphetamine | The risk or severity of hypertension can be increased when Icosapent is combined with 4-Methoxyamphetamine. |
| 4-Bromo-2,5-dimethoxyamphetamine | The risk or severity of hypertension can be increased when Icosapent is combined with 4-Bromo-2,5-dimethoxyamphetamine. |
| Tenamfetamine | The risk or severity of hypertension can be increased when Icosapent is combined with Tenamfetamine. |
| Chlorphentermine | The risk or severity of hypertension can be increased when Icosapent is combined with Chlorphentermine. |
| Dextroamphetamine | The risk or severity of hypertension can be increased when Icosapent is combined with Dextroamphetamine. |
| Phendimetrazine | The risk or severity of hypertension can be increased when Icosapent is combined with Phendimetrazine. |
| Solifenacin | The risk or severity of hypertension can be increased when Icosapent is combined with Solifenacin. |
| Periciazine | The risk or severity of hypertension can be increased when Icosapent is combined with Periciazine. |
| Acepromazine | The risk or severity of hypertension can be increased when Icosapent is combined with Acepromazine. |
| Thioproperazine | The risk or severity of hypertension can be increased when Icosapent is combined with Thioproperazine. |
| Zuclopenthixol | The risk or severity of hypertension can be increased when Icosapent is combined with Zuclopenthixol. |
| Epicaptopril | The risk or severity of hypertension can be increased when Icosapent is combined with Epicaptopril. |
| Clorgiline | The risk or severity of hypertension can be increased when Icosapent is combined with Clorgiline. |
| 1-benzylimidazole | The risk or severity of hypertension can be increased when Icosapent is combined with 1-benzylimidazole. |
| Iproniazid | The risk or severity of hypertension can be increased when Icosapent is combined with Iproniazid. |
| Nialamide | The risk or severity of hypertension can be increased when Icosapent is combined with Nialamide. |
| Lysergic acid diethylamide | The risk or severity of hypertension can be increased when Icosapent is combined with Lysergic acid diethylamide. |
| Dronedarone | The risk or severity of hypertension can be increased when Icosapent is combined with Dronedarone. |
| Flibanserin | The risk or severity of hypertension can be increased when Icosapent is combined with Flibanserin. |